Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis.
Taoming LiuJuan BaiShuni YingSheng LiYunlei PanDeren FangJian-Jun QiaoHong FangPublished in: Journal of asthma and allergy (2021)
Omalizumab may be a potential choice in the treatment of patients with NUV in the real-world life.
Keyphrases